Regulatory & Compliance
Health Canada MDL Registration Guide for Turkish Exporters
At a glanceCanada is one of the world's most systematically organised medical device markets — a clear regulatory framework under Health Canada, transparent class-based registration requirements, and MDSAP as the mandatory QMS audit standard for Class II, III, and IV devices. For Turkish manufacturers targeting North America, Health Canada registration is often the most accessible pathway — and MDSAP certification, now required for Canadian registration, simultaneously satisfies QMS audit requirements for the USA, Brazil, Japan, and Australia.
Part 01
Canada's Medical Device Classification System
| Class | Risk Level | Examples | Pathway |
|---|---|---|---|
| Class I | Lowest | Bandages, tongue depressors, examination gloves | No MDL required — Establishment License only |
| Class II | Low-moderate | Surgical instruments, patient monitoring (non-invasive), contact lenses | MDL + MDSAP (mandatory from 2019) |
| Class III | Moderate-high | Orthopaedic implants, vascular catheters, IVDs for serious conditions | MDL + MDSAP + Safety and Effectiveness Evidence |
| Class IV | Highest | Pacemakers, cardiac stents, cochlear implants | Full premarket review + MDSAP + clinical evidence |
Medical Device Licence (MDL) — The Core Requirement
The Medical Device Licence (MDL) is the primary Health Canada market authorisation for Class II, III, and IV devices. Key requirements:
- Application via Health Canada e-submission portal: MDL applications submitted through HC Link (Health Canada's electronic portal)
- Quality system evidence: MDSAP certificate (mandatory for Class II/III/IV since 2019) — ISO 13485 alone is no longer sufficient for Canadian registration
- Safety and effectiveness summary: Summary of the clinical evidence supporting the device's safety and effectiveness claims
- Labelling: Must comply with MDR (Medical Devices Regulations) Schedule 1 labelling requirements — English and French bilingual labelling is mandatory for Canadian market
- Implication for Turkish manufacturers: A Canadian Importer (the entity placing the device on the Canadian market) is required — typically the Turkish manufacturer's Canadian distributor
Bilingual Labelling — English and French
Canada's Official Languages Act requires that all information on medical device labels be in both English and French. This is a hard regulatory requirement, not optional:
- Device name, intended use, directions for use, warnings, caution statements — all must appear in both languages
- IFU (Instructions for Use) — bilingual version required; French translation must be professional quality, not machine translation
- Packaging artwork must accommodate both languages — factor bilingual design into your Canadian launch timeline and cost
- Quebec-specific requirement: Quebec's language laws (Bill 96 / Loi 101) impose stricter French requirements for packaging sold in Quebec — French must be at least as prominent as English
MDSAP — The New Mandatory QMS Standard
Since January 1, 2019, Health Canada mandates MDSAP certification for all Class II, III, and IV medical device manufacturers seeking Canadian registration (with limited exceptions for custom devices and certain Class II devices not previously requiring QMS certification).
The MDSAP audit, conducted by an MDSAP-authorised organisation (BSI, SGS, TÜV SÜD, DNV, etc.), covers your QMS against the requirements of all five MDSAP participating countries simultaneously. The MDSAP certificate replaces separate national QMS audit requirements for Canada, USA, Brazil, Japan, and Australia.
If you do not yet have MDSAP certification, the path to Canadian registration is: ISO 13485 gap assessment → MDSAP gap assessment → QMS upgrade → MDSAP initial audit → MDL application submission.
Part 05MDL Timeline and Costs
| Cost/Timeline Element | Estimate |
|---|---|
| MDSAP certification (initial audit, new to MDSAP) | CAD 15,000–25,000 |
| MDSAP annual surveillance | CAD 8,000–15,000/year |
| Health Canada MDL user fee (Class II) | CAD 3,820 (FY2026) |
| Health Canada MDL user fee (Class III) | CAD 7,640 (FY2026) |
| Regulatory consultant (MDL preparation) | CAD 8,000–20,000 |
| Bilingual labelling (translation + artwork) | CAD 2,000–8,000 per SKU |
| Total Class II MDL timeline | 9–18 months from MDSAP audit completion |
| Total Class III MDL timeline | 12–24 months |
Post-Registration Requirements
- MDL annual renewal: MDLs must be renewed annually with payment of renewal fees; failure to renew causes automatic expiry
- Mandatory problem reporting: Serious injuries and malfunctions must be reported to Health Canada within 10 days (life-threatening) or 30 days (serious injury)
- Recall reporting: All recalls must be reported to Health Canada — Health Canada publishes recalls publicly
- Distribution records: Canadian importers must maintain distribution records enabling batch-level recall traceability
- Establishment license: Canadian importer must hold a valid Establishment License (EL) — renewed annually, issued by Health Canada
Health Canada MDL registration is one of the world's most systematically organised regulatory pathways — clear class definitions, transparent documentation requirements, and MDSAP as the QMS audit standard that simultaneously opens five markets. For Turkish manufacturers targeting Canada, the practical path is: achieve MDSAP certification (which also covers USA, Brazil, Japan, Australia), prepare bilingual EN/FR labelling, appoint a Canadian importer with a valid Establishment License, and submit an MDL application through HC Link. The Canadian market — CAD 3.5 billion annual medical device spend, stable procurement, and English/French bilingual access — rewards the regulatory investment substantially.